vs

Side-by-side financial comparison of EPR PROPERTIES (EPR) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.

EPR PROPERTIES is the larger business by last-quarter revenue ($182.9M vs $168.4M, roughly 1.1× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 3.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 4.6%).

EPR Properties, formerly Entertainment Properties Trust, is a real estate investment trust based in Kansas City, Missouri, that invests in amusement parks, movie theaters, ski resorts, and other entertainment properties. It owns 353 properties as of 2022.

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.

EPR vs ESPR — Head-to-Head

Bigger by revenue
EPR
EPR
1.1× larger
EPR
$182.9M
$168.4M
ESPR
Growing faster (revenue YoY)
ESPR
ESPR
+140.5% gap
ESPR
143.7%
3.2%
EPR
Faster 2-yr revenue CAGR
ESPR
ESPR
Annualised
ESPR
10.6%
4.6%
EPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EPR
EPR
ESPR
ESPR
Revenue
$182.9M
$168.4M
Net Profit
$66.9M
Gross Margin
Operating Margin
56.8%
50.6%
Net Margin
36.6%
Revenue YoY
3.2%
143.7%
Net Profit YoY
897.0%
EPS (diluted)
$0.80
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPR
EPR
ESPR
ESPR
Q4 25
$182.9M
$168.4M
Q3 25
$182.3M
$87.3M
Q2 25
$178.1M
$82.4M
Q1 25
$175.0M
$65.0M
Q4 24
$177.2M
$69.1M
Q3 24
$180.5M
$51.6M
Q2 24
$173.1M
$73.8M
Q1 24
$167.2M
$137.7M
Net Profit
EPR
EPR
ESPR
ESPR
Q4 25
$66.9M
Q3 25
$66.6M
$-31.3M
Q2 25
$75.6M
$-12.7M
Q1 25
$65.8M
$-40.5M
Q4 24
$-8.4M
Q3 24
$46.6M
$-29.5M
Q2 24
$45.1M
$-61.9M
Q1 24
$62.7M
$61.0M
Operating Margin
EPR
EPR
ESPR
ESPR
Q4 25
56.8%
50.6%
Q3 25
53.5%
-11.4%
Q2 25
62.5%
8.6%
Q1 25
58.1%
-34.0%
Q4 24
25.5%
-6.4%
Q3 24
51.4%
-31.0%
Q2 24
45.9%
3.5%
Q1 24
58.8%
52.5%
Net Margin
EPR
EPR
ESPR
ESPR
Q4 25
36.6%
Q3 25
36.5%
-35.9%
Q2 25
42.5%
-15.4%
Q1 25
37.6%
-62.2%
Q4 24
-4.7%
Q3 24
25.8%
-57.2%
Q2 24
26.1%
-83.9%
Q1 24
37.5%
44.3%
EPS (diluted)
EPR
EPR
ESPR
ESPR
Q4 25
$0.80
$0.32
Q3 25
$0.79
$-0.16
Q2 25
$0.91
$-0.06
Q1 25
$0.78
$-0.21
Q4 24
$-0.19
$-0.14
Q3 24
$0.53
$-0.15
Q2 24
$0.51
$-0.33
Q1 24
$0.75
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPR
EPR
ESPR
ESPR
Cash + ST InvestmentsLiquidity on hand
$90.6M
$167.9M
Total DebtLower is stronger
$2.9B
Stockholders' EquityBook value
$2.3B
$-302.0M
Total Assets
$5.7B
$465.9M
Debt / EquityLower = less leverage
1.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPR
EPR
ESPR
ESPR
Q4 25
$90.6M
$167.9M
Q3 25
$13.7M
$92.4M
Q2 25
$13.0M
$86.1M
Q1 25
$20.6M
$114.6M
Q4 24
$22.1M
$144.8M
Q3 24
$35.3M
$144.7M
Q2 24
$33.7M
$189.3M
Q1 24
$59.5M
$226.6M
Total Debt
EPR
EPR
ESPR
ESPR
Q4 25
$2.9B
Q3 25
$2.8B
Q2 25
$2.8B
Q1 25
$2.8B
Q4 24
$2.9B
Q3 24
$2.9B
Q2 24
$2.8B
Q1 24
$2.8B
Stockholders' Equity
EPR
EPR
ESPR
ESPR
Q4 25
$2.3B
$-302.0M
Q3 25
$2.3B
$-451.4M
Q2 25
$2.3B
$-433.5M
Q1 25
$2.3B
$-426.2M
Q4 24
$2.3B
$-388.7M
Q3 24
$2.4B
$-370.2M
Q2 24
$2.4B
$-344.2M
Q1 24
$2.4B
$-294.3M
Total Assets
EPR
EPR
ESPR
ESPR
Q4 25
$5.7B
$465.9M
Q3 25
$5.5B
$364.0M
Q2 25
$5.6B
$347.1M
Q1 25
$5.5B
$324.0M
Q4 24
$5.6B
$343.8M
Q3 24
$5.7B
$314.1M
Q2 24
$5.6B
$352.3M
Q1 24
$5.7B
$373.1M
Debt / Equity
EPR
EPR
ESPR
ESPR
Q4 25
1.26×
Q3 25
1.19×
Q2 25
1.20×
Q1 25
1.20×
Q4 24
1.23×
Q3 24
1.19×
Q2 24
1.16×
Q1 24
1.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPR
EPR
ESPR
ESPR
Operating Cash FlowLast quarter
$421.0M
$45.2M
Free Cash FlowOCF − Capex
$269.2M
FCF MarginFCF / Revenue
147.1%
Capex IntensityCapex / Revenue
82.9%
0.0%
Cash ConversionOCF / Net Profit
6.29×
TTM Free Cash FlowTrailing 4 quarters
$568.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPR
EPR
ESPR
ESPR
Q4 25
$421.0M
$45.2M
Q3 25
$136.5M
$-4.3M
Q2 25
$87.3M
$-31.4M
Q1 25
$99.4M
$-22.6M
Q4 24
$393.1M
$-35.0M
Q3 24
$122.0M
$-35.3M
Q2 24
$78.7M
$-7.2M
Q1 24
$99.5M
$53.8M
Free Cash Flow
EPR
EPR
ESPR
ESPR
Q4 25
$269.2M
Q3 25
$132.1M
Q2 25
$82.4M
Q1 25
$84.7M
Q4 24
$129.2M
Q3 24
$121.5M
$-35.5M
Q2 24
$71.3M
$-7.3M
Q1 24
$65.0M
$53.8M
FCF Margin
EPR
EPR
ESPR
ESPR
Q4 25
147.1%
Q3 25
72.5%
Q2 25
46.3%
Q1 25
48.4%
Q4 24
72.9%
Q3 24
67.3%
-68.7%
Q2 24
41.2%
-9.9%
Q1 24
38.9%
39.0%
Capex Intensity
EPR
EPR
ESPR
ESPR
Q4 25
82.9%
0.0%
Q3 25
2.4%
0.0%
Q2 25
2.7%
0.0%
Q1 25
8.4%
0.0%
Q4 24
148.9%
0.0%
Q3 24
0.3%
0.3%
Q2 24
4.2%
0.1%
Q1 24
20.6%
0.1%
Cash Conversion
EPR
EPR
ESPR
ESPR
Q4 25
6.29×
Q3 25
2.05×
Q2 25
1.15×
Q1 25
1.51×
Q4 24
Q3 24
2.62×
Q2 24
1.74×
Q1 24
1.59×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EPR
EPR

Experiential Reportable Operating Segment$173.3M95%
Education Reportable Operating Segment$9.5M5%

ESPR
ESPR

Collaboration Revenue$124.7M74%
Products$43.7M26%

Related Comparisons